Viewing Study NCT01000506


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2025-12-26 @ 2:40 PM
Study NCT ID: NCT01000506
Status: COMPLETED
Last Update Posted: 2018-01-24
First Post: 2009-10-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
Sponsor: GlaxoSmithKline
Organization: